Nesina (alogliptin) Tablets, for Oral Use

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)   April 2016 WARNINGS AND PRECAUTIONS Pancreatitis Acute pancreatitis has been reported in the postmarketing setting and in...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts